Referencer - Behandlingsvejledning

1. De Herdt V, De Waele J, Raedt R, Wyckhuys T, El Tahry R, Vonck K, et al.Modulationof seizure threshold by vagus nerve stimulation in an animal model for motor seizures. Acta NeurolScand. 2010;121(4):271-6.
2. Vonck K, De Herdt V, Bosman T, Dedeurwaerdere S, Van Laere K, Boon P. Thalamicand limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study.Seizure. 2008;17(8):699-706.
3. Raedt R, Clinckers R, Mollet L, Vonck K, El Tahry R, Wyckhuys T, et al. Increasedhippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbicseizure model.J Neurochem. 2011;117(3):461-9.
4. De Taeye L, Vonck K, van Bochove M, Boon P, Van Roost D, Mollet L, et al.The P3event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients withepilepsy. Neurotherapeutics. 2014;11(3):612-22.
5. Marrosu F, Serra A, Maleci A, Puligheddu M, Biggio G, Piga M. Correlation betweenGABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partialepilepsy.Epilepsy Res. 2003;55(1-2):59-70.
6. Fraschini M, Demuru M, Puligheddu M, Floridia S, Polizzi L, Maleci A, et al.The re-organization of functional brain networks in pharmaco-resistant epileptic patients who respond toVNS. Neurosci Lett. 2014;580:153-7.
7. Wostyn S, Staljanssens W, De Taeye L, Strobbe G, Gadeyne S, Van Roost D, et al.EEGDerived Brain Activity Reflects Treatment Response from Vagus Nerve Stimulation in Patients withEpilepsy. Int J Neural Syst. 2017;27(4):1650048.
8. Toffa DH, Touma L, El Meskine T, Bouthillier A, Nguyen DK. Learnings from 30 yearsof reported efficacy andsafety of vagus nerve stimulation (VNS) for epilepsy treatment: A criticalreview. Seizure. 2020;83:104-23.
9. Carrette S, Boon P, Vonck K. A prestimulation evaluation protocol for patients withdrug resistant epilepsy. Seizure. 2017;44:137-42.
10. Renfroe JB, Wheless JW. Earlier use of adjunctive vagus nerve stimulation therapy forrefractory epilepsy. Neurology. 2002;59(6 Suppl 4):S26-30.
11. Elliott RE, Morsi A, Tanweer O, Grobelny B, Geller E, Carlson C, et al. Efficacy of vagusnerve stimulation overtime: review of 65 consecutive patients with treatment-resistant epilepsytreated with VNS > 10 years. Epilepsy Behav. 2011;20(3):478-83.
12. Rossignol E, Lortie A, Thomas T, Bouthiller A, Scavarda D, Mercier C, et al. Vagusnerve stimulation in pediatricepileptic syndromes. Seizure. 2009;18(1):34-7.
13. Gurbani S, Chayasirisobhon S, Cahan L, Choi S, Enos B, Hwang J, et al.Neuromodulation Therapy with Vagus Nerve Stimulation for Intractable Epilepsy: A 2-Year EfficacyAnalysis Study in Patients under 12 Years of Age.Epilepsy Res Treat.2016;2016:9709056.
14. De Herdt V, Boon P, Ceulemans B, Hauman H, Lagae L, Legros B, et al.Vagus nervestimulation for refractory epilepsy: a Belgian multicenter study. Eur J Paediatr Neurol.2007;11(5):261-9.
15. Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, et al.Vagus nervestimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347children. Epilepsia. 2014;55(10):1576-84.
16. Englot DJ, Hassnain KH, Rolston JD, HarwardSC, Sinha SR, Haglund MM. Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data. Epilepsy Behav.2017;66:4-9.
17. Parhizgar F, Nugent K, Raj R. Obstructive sleep apnea and respiratory complicationsassociated with vagus nerve stimulators. Journal of clinical sleep medicine : JCSM : officialpublication of the American Academy of Sleep Medicine.2011;7(4):401-7.